The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,787.59 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 90-count tablets of the medication Daliresp 500 MCG. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. This award is considered a child contract under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific contract award.
Generated 3/17/25, 10:03 AM